Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.

Author: HiraoKeiichi, HondaHirokazu, KobayashiYasuna, OnumaShoko, ShibagakiKeigo, ShibataTakanori, TomosugiNaohisa, YamamotoToshinori, YuzaToshitaka

Paper Details 
Original Abstract of the Article :
We aimed to identify associations between erythroferrone (ERFE), a regulator of hepcidin 25, and biomarkers of erythropoiesis and iron metabolism. We also aimed to determine the effects of erythropoiesis-stimulating agents (ESA), continuous erythropoietin receptor activator (CERA) and darbepoetin-α ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792384/

データ提供:米国国立医学図書館(NLM)

Erythroferrone: A Key Player in Iron Regulation and Erythropoiesis

Iron is a vital mineral, playing a crucial role in oxygen transport and overall health. This study investigates the role of erythroferrone (ERFE), a hormone involved in iron regulation, in patients on hemodialysis. The researchers analyze the relationship between ERFE levels and various biomarkers of erythropoiesis and iron metabolism, exploring the complex interplay of these factors in hemodialysis patients.

Erythroferrone: A New Understanding of Iron Regulation in Hemodialysis

This research provides valuable insights into the role of ERFE in iron regulation and erythropoiesis in hemodialysis patients. The study highlights the complex relationship between ERFE and other biomarkers, underscoring the importance of understanding this interplay for optimizing iron management in these patients.

Erythroferrone: Optimizing Iron Management in Hemodialysis Patients

This research underscores the importance of considering ERFE levels when managing iron in hemodialysis patients. The study's findings offer potential for developing new strategies for optimizing iron management and improving overall health outcomes in these patients.

Dr.Camel's Conclusion

Just as a camel navigates the vast and unpredictable desert, this research explores the intricate pathways of iron regulation in hemodialysis patients. Erythroferrone emerges as a crucial player in this complex process, offering a new understanding of iron management and potential avenues for improving health outcomes.

Date :
  1. Date Completed 2016-07-26
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

26978524

DOI: Digital Object Identifier

PMC4792384

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.